408 related articles for article (PubMed ID: 9625122)
1. Effects of alendronate on gastric and duodenal mucosa.
Lanza F; Rack MF; Simon TJ; Lombardi A; Reyes R; Suryawanshi S
Am J Gastroenterol; 1998 May; 93(5):753-7. PubMed ID: 9625122
[TBL] [Abstract][Full Text] [Related]
2. An endoscopic comparison of the effects of alendronate and risedronate on upper gastrointestinal mucosae.
Lanza F; Schwartz H; Sahba B; Malaty HM; Musliner T; Reyes R; Quan H; Graham DY
Am J Gastroenterol; 2000 Nov; 95(11):3112-7. PubMed ID: 11095326
[TBL] [Abstract][Full Text] [Related]
3. Upper GI mucosal effects of parecoxib sodium in healthy elderly subjects.
Stoltz RR; Harris SI; Kuss ME; LeComte D; Talwalker S; Dhadda S; Hubbard RC
Am J Gastroenterol; 2002 Jan; 97(1):65-71. PubMed ID: 11808971
[TBL] [Abstract][Full Text] [Related]
4. 14 day endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by Helicobacter pylori status.
Thomson AB; Marshall JK; Hunt RH; Provenza JM; Lanza FL; Royer MG; Li Z; Blank MA;
J Rheumatol; 2002 Sep; 29(9):1965-74. PubMed ID: 12233894
[TBL] [Abstract][Full Text] [Related]
5. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S
Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
[TBL] [Abstract][Full Text] [Related]
6. The upper GI safety and tolerability of oral alendronate at a dose of 70 milligrams once weekly: a placebo-controlled endoscopy study.
Lanza F; Sahba B; Schwartz H; Winograd S; Torosis J; Quan H; Reyes R; Musliner T; Daifotis A; Leung A
Am J Gastroenterol; 2002 Jan; 97(1):58-64. PubMed ID: 11808969
[TBL] [Abstract][Full Text] [Related]
7. Effects of ibuprofen lysinate and acetylsalicylic acid on gastric and duodenal mucosa. Randomized single-blind placebo-controlled endoscopic study in healthy volunteers.
Müller P; Simon B
Arzneimittelforschung; 1994 Jul; 44(7):840-3. PubMed ID: 7945519
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
Bianchi Porro G; Lazzaroni M; Petrillo M
Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
[TBL] [Abstract][Full Text] [Related]
9. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial.
Feldman M; Cryer B; Mallat D; Go MF
Am J Gastroenterol; 2001 Jun; 96(6):1751-7. PubMed ID: 11419825
[TBL] [Abstract][Full Text] [Related]
10. Primary amino-bisphosphonates: a new class of gastrotoxic drugs--comparison of alendronate and aspirin.
Graham DY; Malaty HM; Goodgame R
Am J Gastroenterol; 1997 Aug; 92(8):1322-5. PubMed ID: 9260798
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, placebo-controlled, 6-day evaluation of two doses of misoprostol in gastroduodenal mucosal protection against damage from aspirin and effect on bowel habits.
Lanza FL; Kochman RL; Geis GS; Rack EM; Deysach LG
Am J Gastroenterol; 1991 Dec; 86(12):1743-8. PubMed ID: 1962619
[TBL] [Abstract][Full Text] [Related]
12. Upper gastrointestinal toxicity of alendronate.
Lowe CE; Depew WT; Vanner SJ; Paterson WG; Meddings JB
Am J Gastroenterol; 2000 Mar; 95(3):634-40. PubMed ID: 10710050
[TBL] [Abstract][Full Text] [Related]
13. [Aspirin and gastroduodenal toxicity. A double-blind endoscopic study of the effects of placebo, aspirin and lysine acetylsalicylate in healthy subjects].
Bretagne JF; Feuillu A; Gosselin M; Gastard J
Gastroenterol Clin Biol; 1984 Jan; 8(1):28-32. PubMed ID: 6698337
[TBL] [Abstract][Full Text] [Related]
14. Investigation of gastroduodenal mucosal injuries caused by low-dose aspirin therapy in patients with cerebral infarction.
Nema H; Kato M
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S119-21. PubMed ID: 20586852
[TBL] [Abstract][Full Text] [Related]
15. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
Giral A; Ozdogan O; Celikel CA; Tozun N; Ulusoy NB; Kalayci C
J Gastroenterol Hepatol; 2004 Jul; 19(7):773-7. PubMed ID: 15209624
[TBL] [Abstract][Full Text] [Related]
16. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration.
Lanza F; Peace K; Gustitus L; Rack MF; Dickson B
Am J Gastroenterol; 1988 Feb; 83(2):143-6. PubMed ID: 3124604
[TBL] [Abstract][Full Text] [Related]
17. An endoscopic comparison of gastroduodenal injury with over-the-counter doses of ketoprofen and acetaminophen.
Lanza FL; Codispoti JR; Nelson EB
Am J Gastroenterol; 1998 Jul; 93(7):1051-4. PubMed ID: 9672328
[TBL] [Abstract][Full Text] [Related]
18. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Goldstein JL; Huang B; Amer F; Christopoulos NG
Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
[TBL] [Abstract][Full Text] [Related]
19. A comparative endoscopic evaluation of the damaging effects of nonsteroidal anti-inflammatory agents on the gastric and duodenal mucosa.
Lanza FL; Royer GL; Nelson RS; Chen TT; Seckman CE; Rack MF
Am J Gastroenterol; 1981 Jan; 75(1):17-21. PubMed ID: 7234826
[TBL] [Abstract][Full Text] [Related]
20. Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled, exploratory study.
Adachi JD; Faraawi RY; O'Mahony MF; Nayar A; Massaad R; Evans JK; Yacik C
Clin Ther; 2009 Aug; 31(8):1747-53. PubMed ID: 19808133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]